CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BioBlood aims to revolutionize personalized medicine in hematology by developing a platform for producing red blood cells and optimizing drug treatments tailored to individual patients. This approach addresses the challenges of blood supply and treatment efficacy in hematological cancers.
Personalized medicine is a medical model that proposes the customization of healthcare, with decisions and practices being tailored to the individual patient by use of patient-specific information and/or application of patient-specific cell-based therapies.
BioBlood aims to deliver personalised healthcare through a “step change” in the clinical field of haemato-oncology.
BioBlood represents an engineered bio-inspired integrated experimental/modelling platform for normal and abnormal haematopoies…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
